Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ken Onodera
Growth Inhibition of KRAS‑�and EGFR‑mutant Lung Adenocarcinoma by Cosuppression of STAT3 and the SRC/ARHGAP35 Axis
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
MerTK Mediates STAT3–KRAS/SRC-signaling Axis for Glioma Stem Cell Maintenance
Artificial Cells, Nanomedicine and Biotechnology
Medicine
Biotechnology
Biomedical Engineering
Pharmaceutical Science
P010 Relationship Between EGFR and KRAS Mutation and the Clinicopathologic Features of Early Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ΙκΒ Kinase Α Is Required for Development and Progression of KRAS-mutant Lung Adenocarcinoma.
Cancer Research
Cancer Research
Oncology
MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition
PLoS ONE
Multidisciplinary
SKA3 Promotes Lung Adenocarcinoma Metastasis Through the EGFR-PI3K-Akt Axis
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
PLoS ONE
Multidisciplinary
P14ARF Inhibits the Growth of Lung Adenocarcinoma Cells Harbouring an EGFR L858R Mutation by Activating a STAT3-dependent Pro-Apoptotic Signalling Pathway
Oncogene
Cancer Research
Genetics
Molecular Biology
P2.01-09 Targetable Genomic Alterations in KRAS Mutant Lung Adenocarcinoma by Targeted Next Generation Sequencing
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Inhibition of Hsp90 Down-Regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel
Cancer Research
Cancer Research
Oncology
